nodes	percent_of_prediction	percent_of_DWPC	metapath
Entecavir—Decitabine—Gemcitabine—kidney cancer	0.702	1	CrCrCtD
Entecavir—Neutropenia—Paclitaxel—kidney cancer	0.000485	0.00163	CcSEcCtD
Entecavir—Diarrhoea—Temsirolimus—kidney cancer	0.000484	0.00162	CcSEcCtD
Entecavir—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.000482	0.00162	CcSEcCtD
Entecavir—Leukopenia—Sunitinib—kidney cancer	0.000482	0.00162	CcSEcCtD
Entecavir—Asthenia—Pazopanib—kidney cancer	0.000478	0.0016	CcSEcCtD
Entecavir—Insomnia—Everolimus—kidney cancer	0.000476	0.0016	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000473	0.00159	CcSEcCtD
Entecavir—Hyperglycaemia—Paclitaxel—kidney cancer	0.000468	0.00157	CcSEcCtD
Entecavir—Somnolence—Everolimus—kidney cancer	0.000468	0.00157	CcSEcCtD
Entecavir—Dizziness—Temsirolimus—kidney cancer	0.000468	0.00157	CcSEcCtD
Entecavir—Dyspepsia—Everolimus—kidney cancer	0.000463	0.00155	CcSEcCtD
Entecavir—Alopecia—Vincristine—kidney cancer	0.000462	0.00155	CcSEcCtD
Entecavir—Blood creatinine increased—Capecitabine—kidney cancer	0.000462	0.00155	CcSEcCtD
Entecavir—Insomnia—Erlotinib—kidney cancer	0.000459	0.00154	CcSEcCtD
Entecavir—Mental disorder—Vincristine—kidney cancer	0.000458	0.00154	CcSEcCtD
Entecavir—Anaphylactic shock—Sorafenib—kidney cancer	0.000456	0.00153	CcSEcCtD
Entecavir—Leukopenia—Dactinomycin—kidney cancer	0.000456	0.00153	CcSEcCtD
Entecavir—Diarrhoea—Pazopanib—kidney cancer	0.000456	0.00153	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000455	0.00153	CcSEcCtD
Entecavir—Renal failure—Paclitaxel—kidney cancer	0.000455	0.00153	CcSEcCtD
Entecavir—Gastrointestinal disorder—Everolimus—kidney cancer	0.000454	0.00152	CcSEcCtD
Entecavir—Infection—Sorafenib—kidney cancer	0.000454	0.00152	CcSEcCtD
Entecavir—Fatigue—Everolimus—kidney cancer	0.000453	0.00152	CcSEcCtD
Entecavir—Abdominal pain upper—Capecitabine—kidney cancer	0.00045	0.00151	CcSEcCtD
Entecavir—Vomiting—Temsirolimus—kidney cancer	0.00045	0.00151	CcSEcCtD
Entecavir—Immune system disorder—Gemcitabine—kidney cancer	0.000448	0.0015	CcSEcCtD
Entecavir—Nervous system disorder—Sorafenib—kidney cancer	0.000448	0.0015	CcSEcCtD
Entecavir—Dyspepsia—Erlotinib—kidney cancer	0.000447	0.0015	CcSEcCtD
Entecavir—Rash—Temsirolimus—kidney cancer	0.000446	0.0015	CcSEcCtD
Entecavir—Dermatitis—Temsirolimus—kidney cancer	0.000445	0.00149	CcSEcCtD
Entecavir—Skin disorder—Sorafenib—kidney cancer	0.000443	0.00149	CcSEcCtD
Entecavir—Headache—Temsirolimus—kidney cancer	0.000443	0.00149	CcSEcCtD
Entecavir—Haematuria—Paclitaxel—kidney cancer	0.000441	0.00148	CcSEcCtD
Entecavir—Dizziness—Pazopanib—kidney cancer	0.00044	0.00148	CcSEcCtD
Entecavir—Alopecia—Gemcitabine—kidney cancer	0.000438	0.00147	CcSEcCtD
Entecavir—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000438	0.00147	CcSEcCtD
Entecavir—Hepatobiliary disease—Paclitaxel—kidney cancer	0.000438	0.00147	CcSEcCtD
Entecavir—Fatigue—Erlotinib—kidney cancer	0.000437	0.00147	CcSEcCtD
Entecavir—Infection—Sunitinib—kidney cancer	0.000436	0.00146	CcSEcCtD
Entecavir—Gastrointestinal pain—Vinblastine—kidney cancer	0.000432	0.00145	CcSEcCtD
Entecavir—Nervous system disorder—Sunitinib—kidney cancer	0.000431	0.00145	CcSEcCtD
Entecavir—Gastrointestinal pain—Everolimus—kidney cancer	0.00043	0.00144	CcSEcCtD
Entecavir—Skin disorder—Sunitinib—kidney cancer	0.000427	0.00143	CcSEcCtD
Entecavir—Vomiting—Pazopanib—kidney cancer	0.000423	0.00142	CcSEcCtD
Entecavir—Rash—Pazopanib—kidney cancer	0.00042	0.00141	CcSEcCtD
Entecavir—Nausea—Temsirolimus—kidney cancer	0.00042	0.00141	CcSEcCtD
Entecavir—Dermatitis—Pazopanib—kidney cancer	0.00042	0.00141	CcSEcCtD
Entecavir—Abdominal pain—Vinblastine—kidney cancer	0.000417	0.0014	CcSEcCtD
Entecavir—Headache—Pazopanib—kidney cancer	0.000417	0.0014	CcSEcCtD
Entecavir—Body temperature increased—Everolimus—kidney cancer	0.000416	0.0014	CcSEcCtD
Entecavir—Abdominal pain—Everolimus—kidney cancer	0.000416	0.0014	CcSEcCtD
Entecavir—Gastrointestinal pain—Erlotinib—kidney cancer	0.000415	0.00139	CcSEcCtD
Entecavir—Infection—Dactinomycin—kidney cancer	0.000413	0.00139	CcSEcCtD
Entecavir—Oedema peripheral—Paclitaxel—kidney cancer	0.000409	0.00137	CcSEcCtD
Entecavir—Leukopenia—Vincristine—kidney cancer	0.000407	0.00137	CcSEcCtD
Entecavir—Dyspepsia—Sorafenib—kidney cancer	0.000402	0.00135	CcSEcCtD
Entecavir—Body temperature increased—Erlotinib—kidney cancer	0.000401	0.00135	CcSEcCtD
Entecavir—Abdominal pain—Erlotinib—kidney cancer	0.000401	0.00135	CcSEcCtD
Entecavir—Neutropenia—Capecitabine—kidney cancer	0.000398	0.00134	CcSEcCtD
Entecavir—Insomnia—Sunitinib—kidney cancer	0.000397	0.00133	CcSEcCtD
Entecavir—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000396	0.00133	CcSEcCtD
Entecavir—Nausea—Pazopanib—kidney cancer	0.000396	0.00133	CcSEcCtD
Entecavir—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000394	0.00132	CcSEcCtD
Entecavir—Fatigue—Sorafenib—kidney cancer	0.000394	0.00132	CcSEcCtD
Entecavir—Dyspepsia—Sunitinib—kidney cancer	0.000387	0.0013	CcSEcCtD
Entecavir—Leukopenia—Gemcitabine—kidney cancer	0.000387	0.0013	CcSEcCtD
Entecavir—Hyperglycaemia—Capecitabine—kidney cancer	0.000384	0.00129	CcSEcCtD
Entecavir—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000379	0.00127	CcSEcCtD
Entecavir—Asthenia—Vinblastine—kidney cancer	0.000379	0.00127	CcSEcCtD
Entecavir—Fatigue—Sunitinib—kidney cancer	0.000379	0.00127	CcSEcCtD
Entecavir—Asthenia—Everolimus—kidney cancer	0.000377	0.00127	CcSEcCtD
Entecavir—Immune system disorder—Paclitaxel—kidney cancer	0.000375	0.00126	CcSEcCtD
Entecavir—Gastrointestinal pain—Sorafenib—kidney cancer	0.000373	0.00125	CcSEcCtD
Entecavir—Renal failure—Capecitabine—kidney cancer	0.000373	0.00125	CcSEcCtD
Entecavir—Anaphylactic shock—Vincristine—kidney cancer	0.000372	0.00125	CcSEcCtD
Entecavir—Infection—Vincristine—kidney cancer	0.000369	0.00124	CcSEcCtD
Entecavir—Alopecia—Paclitaxel—kidney cancer	0.000367	0.00123	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000365	0.00123	CcSEcCtD
Entecavir—Nervous system disorder—Vincristine—kidney cancer	0.000364	0.00122	CcSEcCtD
Entecavir—Asthenia—Erlotinib—kidney cancer	0.000364	0.00122	CcSEcCtD
Entecavir—Mental disorder—Paclitaxel—kidney cancer	0.000364	0.00122	CcSEcCtD
Entecavir—Haematuria—Capecitabine—kidney cancer	0.000362	0.00122	CcSEcCtD
Entecavir—Malnutrition—Paclitaxel—kidney cancer	0.000362	0.00121	CcSEcCtD
Entecavir—Diarrhoea—Vinblastine—kidney cancer	0.000361	0.00121	CcSEcCtD
Entecavir—Abdominal pain—Sorafenib—kidney cancer	0.000361	0.00121	CcSEcCtD
Entecavir—Body temperature increased—Sorafenib—kidney cancer	0.000361	0.00121	CcSEcCtD
Entecavir—Diarrhoea—Everolimus—kidney cancer	0.00036	0.00121	CcSEcCtD
Entecavir—Gastrointestinal pain—Sunitinib—kidney cancer	0.000359	0.00121	CcSEcCtD
Entecavir—Hepatobiliary disease—Capecitabine—kidney cancer	0.000359	0.00121	CcSEcCtD
Entecavir—Fatigue—Dactinomycin—kidney cancer	0.000359	0.0012	CcSEcCtD
Entecavir—Hepatic failure—Doxorubicin—kidney cancer	0.000353	0.00119	CcSEcCtD
Entecavir—Anaphylactic shock—Gemcitabine—kidney cancer	0.000352	0.00118	CcSEcCtD
Entecavir—Infection—Gemcitabine—kidney cancer	0.00035	0.00118	CcSEcCtD
Entecavir—Dizziness—Vinblastine—kidney cancer	0.000349	0.00117	CcSEcCtD
Entecavir—Dizziness—Everolimus—kidney cancer	0.000348	0.00117	CcSEcCtD
Entecavir—Abdominal pain—Sunitinib—kidney cancer	0.000347	0.00117	CcSEcCtD
Entecavir—Body temperature increased—Sunitinib—kidney cancer	0.000347	0.00117	CcSEcCtD
Entecavir—Diarrhoea—Erlotinib—kidney cancer	0.000347	0.00117	CcSEcCtD
Entecavir—Nervous system disorder—Gemcitabine—kidney cancer	0.000346	0.00116	CcSEcCtD
Entecavir—Skin disorder—Gemcitabine—kidney cancer	0.000342	0.00115	CcSEcCtD
Entecavir—Hepatitis—Capecitabine—kidney cancer	0.000341	0.00114	CcSEcCtD
Entecavir—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00034	0.00114	CcSEcCtD
Entecavir—Insomnia—Vincristine—kidney cancer	0.000336	0.00113	CcSEcCtD
Entecavir—Oedema peripheral—Capecitabine—kidney cancer	0.000336	0.00113	CcSEcCtD
Entecavir—Vomiting—Vinblastine—kidney cancer	0.000336	0.00113	CcSEcCtD
Entecavir—Dizziness—Erlotinib—kidney cancer	0.000336	0.00113	CcSEcCtD
Entecavir—Vomiting—Everolimus—kidney cancer	0.000334	0.00112	CcSEcCtD
Entecavir—Rash—Everolimus—kidney cancer	0.000332	0.00111	CcSEcCtD
Entecavir—Dermatitis—Everolimus—kidney cancer	0.000331	0.00111	CcSEcCtD
Entecavir—Headache—Vinblastine—kidney cancer	0.000331	0.00111	CcSEcCtD
Entecavir—Headache—Everolimus—kidney cancer	0.000329	0.00111	CcSEcCtD
Entecavir—Abdominal pain—Dactinomycin—kidney cancer	0.000329	0.0011	CcSEcCtD
Entecavir—Body temperature increased—Dactinomycin—kidney cancer	0.000329	0.0011	CcSEcCtD
Entecavir—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000328	0.0011	CcSEcCtD
Entecavir—Asthenia—Sorafenib—kidney cancer	0.000328	0.0011	CcSEcCtD
Entecavir—Leukopenia—Paclitaxel—kidney cancer	0.000324	0.00109	CcSEcCtD
Entecavir—Vomiting—Erlotinib—kidney cancer	0.000323	0.00108	CcSEcCtD
Entecavir—Gastrointestinal disorder—Vincristine—kidney cancer	0.000321	0.00108	CcSEcCtD
Entecavir—Fatigue—Vincristine—kidney cancer	0.00032	0.00108	CcSEcCtD
Entecavir—Rash—Erlotinib—kidney cancer	0.00032	0.00107	CcSEcCtD
Entecavir—Dermatitis—Erlotinib—kidney cancer	0.00032	0.00107	CcSEcCtD
Entecavir—Insomnia—Gemcitabine—kidney cancer	0.000319	0.00107	CcSEcCtD
Entecavir—Headache—Erlotinib—kidney cancer	0.000318	0.00107	CcSEcCtD
Entecavir—Asthenia—Sunitinib—kidney cancer	0.000315	0.00106	CcSEcCtD
Entecavir—Nausea—Vinblastine—kidney cancer	0.000314	0.00105	CcSEcCtD
Entecavir—Somnolence—Gemcitabine—kidney cancer	0.000313	0.00105	CcSEcCtD
Entecavir—Nausea—Everolimus—kidney cancer	0.000312	0.00105	CcSEcCtD
Entecavir—Diarrhoea—Sorafenib—kidney cancer	0.000312	0.00105	CcSEcCtD
Entecavir—Immune system disorder—Capecitabine—kidney cancer	0.000308	0.00103	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000306	0.00103	CcSEcCtD
Entecavir—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000304	0.00102	CcSEcCtD
Entecavir—Fatigue—Gemcitabine—kidney cancer	0.000304	0.00102	CcSEcCtD
Entecavir—Gastrointestinal pain—Vincristine—kidney cancer	0.000304	0.00102	CcSEcCtD
Entecavir—Dizziness—Sorafenib—kidney cancer	0.000302	0.00101	CcSEcCtD
Entecavir—Nausea—Erlotinib—kidney cancer	0.000301	0.00101	CcSEcCtD
Entecavir—Alopecia—Capecitabine—kidney cancer	0.000301	0.00101	CcSEcCtD
Entecavir—Diarrhoea—Sunitinib—kidney cancer	0.000301	0.00101	CcSEcCtD
Entecavir—Mental disorder—Capecitabine—kidney cancer	0.000299	0.001	CcSEcCtD
Entecavir—Asthenia—Dactinomycin—kidney cancer	0.000298	0.001	CcSEcCtD
Entecavir—Blood creatinine increased—Doxorubicin—kidney cancer	0.000298	0.000999	CcSEcCtD
Entecavir—Malnutrition—Capecitabine—kidney cancer	0.000297	0.000996	CcSEcCtD
Entecavir—Anaphylactic shock—Paclitaxel—kidney cancer	0.000295	0.00099	CcSEcCtD
Entecavir—Abdominal pain—Vincristine—kidney cancer	0.000294	0.000986	CcSEcCtD
Entecavir—Body temperature increased—Vincristine—kidney cancer	0.000294	0.000986	CcSEcCtD
Entecavir—Infection—Paclitaxel—kidney cancer	0.000293	0.000984	CcSEcCtD
Entecavir—Dizziness—Sunitinib—kidney cancer	0.00029	0.000975	CcSEcCtD
Entecavir—Vomiting—Sorafenib—kidney cancer	0.00029	0.000974	CcSEcCtD
Entecavir—Abdominal pain upper—Doxorubicin—kidney cancer	0.00029	0.000974	CcSEcCtD
Entecavir—Nervous system disorder—Paclitaxel—kidney cancer	0.000289	0.000971	CcSEcCtD
Entecavir—Rash—Sorafenib—kidney cancer	0.000288	0.000966	CcSEcCtD
Entecavir—Dermatitis—Sorafenib—kidney cancer	0.000288	0.000965	CcSEcCtD
Entecavir—Skin disorder—Paclitaxel—kidney cancer	0.000287	0.000962	CcSEcCtD
Entecavir—Headache—Sorafenib—kidney cancer	0.000286	0.00096	CcSEcCtD
Entecavir—Diarrhoea—Dactinomycin—kidney cancer	0.000285	0.000955	CcSEcCtD
Entecavir—Vomiting—Sunitinib—kidney cancer	0.000279	0.000937	CcSEcCtD
Entecavir—Body temperature increased—Gemcitabine—kidney cancer	0.000279	0.000935	CcSEcCtD
Entecavir—Rash—Sunitinib—kidney cancer	0.000277	0.00093	CcSEcCtD
Entecavir—Dermatitis—Sunitinib—kidney cancer	0.000277	0.000929	CcSEcCtD
Entecavir—Headache—Sunitinib—kidney cancer	0.000275	0.000924	CcSEcCtD
Entecavir—Nausea—Sorafenib—kidney cancer	0.000271	0.00091	CcSEcCtD
Entecavir—Pancreatitis—Doxorubicin—kidney cancer	0.000269	0.000903	CcSEcCtD
Entecavir—Insomnia—Paclitaxel—kidney cancer	0.000267	0.000896	CcSEcCtD
Entecavir—Asthenia—Vincristine—kidney cancer	0.000267	0.000895	CcSEcCtD
Entecavir—Leukopenia—Capecitabine—kidney cancer	0.000266	0.000891	CcSEcCtD
Entecavir—Vomiting—Dactinomycin—kidney cancer	0.000264	0.000887	CcSEcCtD
Entecavir—Somnolence—Paclitaxel—kidney cancer	0.000262	0.00088	CcSEcCtD
Entecavir—Rash—Dactinomycin—kidney cancer	0.000262	0.00088	CcSEcCtD
Entecavir—Nausea—Sunitinib—kidney cancer	0.000261	0.000876	CcSEcCtD
Entecavir—Dyspepsia—Paclitaxel—kidney cancer	0.00026	0.000872	CcSEcCtD
Entecavir—Neutropenia—Doxorubicin—kidney cancer	0.000257	0.000861	CcSEcCtD
Entecavir—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000255	0.000856	CcSEcCtD
Entecavir—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000255	0.000855	CcSEcCtD
Entecavir—Fatigue—Paclitaxel—kidney cancer	0.000254	0.000854	CcSEcCtD
Entecavir—Diarrhoea—Vincristine—kidney cancer	0.000254	0.000853	CcSEcCtD
Entecavir—Asthenia—Gemcitabine—kidney cancer	0.000253	0.000849	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000251	0.000842	CcSEcCtD
Entecavir—Hyperglycaemia—Doxorubicin—kidney cancer	0.000248	0.000831	CcSEcCtD
Entecavir—Nausea—Dactinomycin—kidney cancer	0.000247	0.000829	CcSEcCtD
Entecavir—Dizziness—Vincristine—kidney cancer	0.000246	0.000825	CcSEcCtD
Entecavir—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000241	0.00081	CcSEcCtD
Entecavir—Diarrhoea—Gemcitabine—kidney cancer	0.000241	0.000809	CcSEcCtD
Entecavir—Renal failure—Doxorubicin—kidney cancer	0.000241	0.000807	CcSEcCtD
Entecavir—Infection—Capecitabine—kidney cancer	0.000241	0.000807	CcSEcCtD
Entecavir—Nervous system disorder—Capecitabine—kidney cancer	0.000237	0.000797	CcSEcCtD
Entecavir—Vomiting—Vincristine—kidney cancer	0.000236	0.000793	CcSEcCtD
Entecavir—Skin disorder—Capecitabine—kidney cancer	0.000235	0.000789	CcSEcCtD
Entecavir—Rash—Vincristine—kidney cancer	0.000234	0.000786	CcSEcCtD
Entecavir—Dermatitis—Vincristine—kidney cancer	0.000234	0.000785	CcSEcCtD
Entecavir—Haematuria—Doxorubicin—kidney cancer	0.000233	0.000783	CcSEcCtD
Entecavir—Body temperature increased—Paclitaxel—kidney cancer	0.000233	0.000783	CcSEcCtD
Entecavir—Abdominal pain—Paclitaxel—kidney cancer	0.000233	0.000783	CcSEcCtD
Entecavir—Headache—Vincristine—kidney cancer	0.000233	0.000781	CcSEcCtD
Entecavir—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000231	0.000777	CcSEcCtD
Entecavir—Vomiting—Gemcitabine—kidney cancer	0.000224	0.000752	CcSEcCtD
Entecavir—Rash—Gemcitabine—kidney cancer	0.000222	0.000746	CcSEcCtD
Entecavir—Dermatitis—Gemcitabine—kidney cancer	0.000222	0.000745	CcSEcCtD
Entecavir—Headache—Gemcitabine—kidney cancer	0.000221	0.000741	CcSEcCtD
Entecavir—Nausea—Vincristine—kidney cancer	0.000221	0.000741	CcSEcCtD
Entecavir—Hepatitis—Doxorubicin—kidney cancer	0.00022	0.000737	CcSEcCtD
Entecavir—Insomnia—Capecitabine—kidney cancer	0.000219	0.000735	CcSEcCtD
Entecavir—Oedema peripheral—Doxorubicin—kidney cancer	0.000216	0.000726	CcSEcCtD
Entecavir—Dyspepsia—Capecitabine—kidney cancer	0.000213	0.000715	CcSEcCtD
Entecavir—Asthenia—Paclitaxel—kidney cancer	0.000212	0.000711	CcSEcCtD
Entecavir—Nausea—Gemcitabine—kidney cancer	0.000209	0.000703	CcSEcCtD
Entecavir—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000209	0.000702	CcSEcCtD
Entecavir—Fatigue—Capecitabine—kidney cancer	0.000209	0.000701	CcSEcCtD
Entecavir—Diarrhoea—Paclitaxel—kidney cancer	0.000202	0.000678	CcSEcCtD
Entecavir—Immune system disorder—Doxorubicin—kidney cancer	0.000198	0.000666	CcSEcCtD
Entecavir—Gastrointestinal pain—Capecitabine—kidney cancer	0.000198	0.000665	CcSEcCtD
Entecavir—Dizziness—Paclitaxel—kidney cancer	0.000195	0.000655	CcSEcCtD
Entecavir—Alopecia—Doxorubicin—kidney cancer	0.000194	0.000652	CcSEcCtD
Entecavir—Mental disorder—Doxorubicin—kidney cancer	0.000192	0.000646	CcSEcCtD
Entecavir—Body temperature increased—Capecitabine—kidney cancer	0.000191	0.000642	CcSEcCtD
Entecavir—Abdominal pain—Capecitabine—kidney cancer	0.000191	0.000642	CcSEcCtD
Entecavir—Malnutrition—Doxorubicin—kidney cancer	0.000191	0.000642	CcSEcCtD
Entecavir—Vomiting—Paclitaxel—kidney cancer	0.000188	0.00063	CcSEcCtD
Entecavir—Rash—Paclitaxel—kidney cancer	0.000186	0.000624	CcSEcCtD
Entecavir—Dermatitis—Paclitaxel—kidney cancer	0.000186	0.000624	CcSEcCtD
Entecavir—Headache—Paclitaxel—kidney cancer	0.000185	0.00062	CcSEcCtD
Entecavir—Nausea—Paclitaxel—kidney cancer	0.000175	0.000588	CcSEcCtD
Entecavir—Asthenia—Capecitabine—kidney cancer	0.000174	0.000583	CcSEcCtD
Entecavir—Leukopenia—Doxorubicin—kidney cancer	0.000171	0.000575	CcSEcCtD
Entecavir—Diarrhoea—Capecitabine—kidney cancer	0.000166	0.000556	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000162	0.000543	CcSEcCtD
Entecavir—Dizziness—Capecitabine—kidney cancer	0.00016	0.000537	CcSEcCtD
Entecavir—Anaphylactic shock—Doxorubicin—kidney cancer	0.000156	0.000524	CcSEcCtD
Entecavir—Infection—Doxorubicin—kidney cancer	0.000155	0.00052	CcSEcCtD
Entecavir—Vomiting—Capecitabine—kidney cancer	0.000154	0.000517	CcSEcCtD
Entecavir—Nervous system disorder—Doxorubicin—kidney cancer	0.000153	0.000514	CcSEcCtD
Entecavir—Rash—Capecitabine—kidney cancer	0.000153	0.000512	CcSEcCtD
Entecavir—Dermatitis—Capecitabine—kidney cancer	0.000153	0.000512	CcSEcCtD
Entecavir—Headache—Capecitabine—kidney cancer	0.000152	0.000509	CcSEcCtD
Entecavir—Skin disorder—Doxorubicin—kidney cancer	0.000152	0.000509	CcSEcCtD
Entecavir—Nausea—Capecitabine—kidney cancer	0.000144	0.000483	CcSEcCtD
Entecavir—Insomnia—Doxorubicin—kidney cancer	0.000141	0.000474	CcSEcCtD
Entecavir—Somnolence—Doxorubicin—kidney cancer	0.000139	0.000466	CcSEcCtD
Entecavir—Dyspepsia—Doxorubicin—kidney cancer	0.000137	0.000461	CcSEcCtD
Entecavir—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000135	0.000452	CcSEcCtD
Entecavir—Fatigue—Doxorubicin—kidney cancer	0.000135	0.000452	CcSEcCtD
Entecavir—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000128	0.000428	CcSEcCtD
Entecavir—Body temperature increased—Doxorubicin—kidney cancer	0.000123	0.000414	CcSEcCtD
Entecavir—Abdominal pain—Doxorubicin—kidney cancer	0.000123	0.000414	CcSEcCtD
Entecavir—Asthenia—Doxorubicin—kidney cancer	0.000112	0.000376	CcSEcCtD
Entecavir—Diarrhoea—Doxorubicin—kidney cancer	0.000107	0.000358	CcSEcCtD
Entecavir—Dizziness—Doxorubicin—kidney cancer	0.000103	0.000346	CcSEcCtD
Entecavir—Vomiting—Doxorubicin—kidney cancer	9.92e-05	0.000333	CcSEcCtD
Entecavir—Rash—Doxorubicin—kidney cancer	9.84e-05	0.00033	CcSEcCtD
Entecavir—Dermatitis—Doxorubicin—kidney cancer	9.83e-05	0.00033	CcSEcCtD
Entecavir—Headache—Doxorubicin—kidney cancer	9.78e-05	0.000328	CcSEcCtD
Entecavir—Nausea—Doxorubicin—kidney cancer	9.27e-05	0.000311	CcSEcCtD
